{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-045152","form_type":"8-K","ticker":"SBC","cik":"0001930313","company_name":"SBC Medical Group Holdings Inc","filed_at":"2024-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.369504+00:00","generated_at":"2026-05-30T01:16:03.563402+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"SBC Medical Q3 revenue $53M (+12% YoY); net income falls to $2M from $8M","bullets":["Q3 revenue $53M (+12% YoY); operating income $13M (-31% YoY, hit by $12.8M stock-based comp).","Q3 net income attributable to SBC was $2M vs $8M in Q3 2023; nine-month net income $40M (+60%).","Nine-month revenue $160M (+23%), EBITDA $68M (+21%), EBITDA margin 42%.","Partner clinics reached 224 as of Sep 30, 2024, up 24 from a year ago.","Stock-based compensation of $12.8M in Q3 related to listing process reduced operating income."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-045152","json":"https://secwatch.observer/filing/0001493152-24-045152.json","markdown":"https://secwatch.observer/filing/0001493152-24-045152.md","text":"https://secwatch.observer/filing/0001493152-24-045152.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1930313/000149315224045152/0001493152-24-045152-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1930313/000149315224045152/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T01:16:03.563402+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}